Form SC 13G/A Response Oncology Inc

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals

Published: 2001-02-05 00:00:00
Submitted: 2001-02-05
0001.txt
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>0001.txt
<TEXT>

                       SECURITY AND EXCHANGE COMMISSION
                          Washington, DC 20549


                               SCHEDULE 13G
                Under the Securities Exchange Act of 1934
                            (Amendment No. 2)



    				 RESPONSE ONCOLOGY INC.
                           (Name of Issuer)

                            Common Stock
                    (Title of Class of Securities)


                          	761232305
                              (Cusip #)




Cusip No.    761232305         13G                Page 1 of 3 Pages

1  Name of Reporting Person
        Dalton, Greiner, Hartman, Maher & Co
        IRS Identification 59-3418454

2) Check the Appropriate box if a Member of a group*

3) SEC Use Only

4) Citizenship or place of Organization
        Delaware Partnership

Number of Shares Beneficially Owned by Each Reporting Person With:

   5) Sole Voting Power
      622,600

   6) Shared Voting Power
      0

   7) Sole Dispositive Power
      622,600

   8) Shared Dispositve Power
      0

9) Aggregate Amount Beneficially owned by each reporting person
      622,600

10) Check Box if the aggregate amount in row (9) excludes certain Shares

11) Percent of Class Represented by Amount in Row 9
      5.20%

12) Type of Reporting Person
      IA

Cusip No.    761232305          13G                Page 2 of 3 Pages

Item 1(a).  Name of Issuer:
            RESPONSE ONCOLOGY INC.

Item 1(b).  Address of Issuer's Principal Executive Office:
            1775 MORIAH WOODS BOULEVARD
            MEMPHIS, TN  38117

Item 2(a).  Name of Person Filing:
            Dalton, Greiner, Hartman, Maher & Co

Item 2(b).  Address of Principal Business Office:
            565 Fifth Ave., Suite 2101
		New York, NY 10017

Item 2(c).  Citizenship:
            Delaware Partnership

Item 2(d).  Title of Class of Securities:
            Common Stock

Item 2(e).  CUSIP Number
            761232305

Item 3.     This statement is filed pursuant to Rules 13d-
            1(b), or 13d-2(b), the person filing is an
            Investment Adviser registered under Section 203
            of the Investment Advisers Act of 1940.

Item 4.  Ownership:
         (a)  Amount beneficially owned:
              622,600 shares

         (b)  Percent of Class:
              5.20%

         (c)  Number of shares as to which such person has:
              (i)  sole power to vote or to direct the vote:
                   622,600 shares
              (ii) shared power to vote or to direct the vote:
                   0 shares
              (iii) sole power to dispose or to direct the disposition:
                   622,600 shares
              (iv) shared power to dispose or to direct the disposition:
                   0 shares

Item 5. Ownership of Five Percent of Less of a Class :
        Not Applicable

Item 6. Ownership of more than five percent on behalf of another person:
        Not Applicable

Item 7. Identification and Classification of the subsidiary which acquired
        the security being reported on by the parent holding company:
        Not Applicable

Item 8. Identification and Classification of Members of the Group:
        Not Applicable

Cusip No.    7621232305       13G                Page 3 of 3 Pages

Item 9. Notice of Dissolution of Group:
        Not Applicable

Item 10. Certification :
        The following certification shall be included if the
        statement is filed pursuant to Rule 13d-1(b):

        By signing below I certify that, to the best of my knowledge
        and belief, the securities referred to above were acquired
        in the ordinary  course of business and were not acquired for
        the purpose of and do not have the effect of changing or
        influencing the control of the issuer of such securities and
        were not acquired in connection with or as a participant in
        any transaction having such purposes of effect.

        After reasonable inquiry and to the best of my knowledge and
        belief, I certify that the information set forth in this
        statement is true, complete and correct.

        February 5, 2001

        Dalton, Greiner, Hartman, Maher & Co
        By : /s/ Michael W. Keeler
        Title : Vice President-Finance
</TEXT>
</DOCUMENT>
Additional Files
FileSequenceDescriptionTypeSize
0000859780-01-000015.txt   Complete submission text file   6441

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.